Drug Trial Radar · NCT00839800
Study to Investigate the Efficacy of Symbicort® SMART.
Last checked: Nov 20, 2026Latest source record: Nov 30, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,091
Actual
Start
Feb 2009
Primary completion
Feb 2011
Study completion Feb 2011
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Feb 10, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to compare the efficacy of Symbicort SMART (Symbicort Turbuhaler 160/4.5μg, one inhalation twice daily plus as needed) with Symbicort Turbuhaler 160/4.5μg, one inhalation twice daily plus terbutaline Turbuhaler 0.4 mg as needed, as asthma therapy
Conditions
- Asthma
Interventions
Symbicort TurbuhalerDrug
160/4.5 µg
Terbutaline TurbuhalerDrug
0.4 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Percentage of Participants Who Had Experienced Asthma Exacerbation(s) at the End of the StudyTime frame: week 52
Locations
109 sites in 12 countries. Site status is shown where the registry gives one.
Research Site
Ciudad de Buenos Aires, Argentina
Research Site
Buenos Aires, Argentina, Argentina
Research Site
Capital Federal, Buenos Aires, Argentina
Research Site
Mar del Plata, Buenos Aires, Argentina
Research Site
Monte Grande, Buenos Aires, Argentina
Research Site
Quilmes, Buenos Aires, Argentina
Research Site
Rosario, Santa Fe Province, Argentina
Research Site
Santa Fe, Santa Fe Province, Argentina
Research Site
San Miguel de Tucumán, Tucumán Province, Argentina
Research Site
Porto Alegre, Brasil, Brazil
Research Site
Belo Horizonte, Minas Gerais, Brazil
Research Site
Juiz de Fora, Minas Gerais, Brazil
Research Site
Rio de Janeiro, Rio de Janeiro, Brazil
Research Site
Porto Alegre, Rio Grande do Sul, Brazil
Research Site
Florianópolis, Santa Catarina, Brazil
Research Site
Santo André, São Paulo, Brazil
Research Site
Chongqing, China
Research Site
Guangzhou, China
Research Site
Nanjing, China
Research Site
Qingdao, China
Research Site
Shanghai, China
Research Site
Xi'an, China
Research Site
Shenyang, Liaoning, China
Research Site
Hangzhou, Zhejiang, China
Research Site
Tres Ríos, Cartago Province, Costa Rica
Research Site
Barrio San Bosco, Provincia de San José, Costa Rica
Research Site
Budapest, Hungary
Research Site
Cegléd, Hungary
Research Site
Debrecen, Hungary
Research Site
Deszk, Hungary
Research Site
Gyula, Hungary
Research Site
Nyíregyháza, Hungary
Research Site
Százhalombatta, Hungary
Research Site
Noida, India
Research Site
Bangalore, Karnataka, India
Research Site
Mangalore, Karnataka, India
Research Site
Mysore, Karnataka, India
Research Site
Trivandrum, Kerala, India
Research Site
Mumbai, Maharashtra, India
Research Site
Nagpur, Maharashtra, India
Showing 40 of 109 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.